Drug-induced pulmonary hypertension?

Area of Science:

• Cardiology
• Pharmacology
• Pulmonology

Background:

• Obstructive pulmonary hypertension is a serious condition affecting pulmonary arteries.
• Identifying the causes of pulmonary hypertension is crucial for effective treatment.

Purpose of the Study:

• To investigate a potential association between aminorex fumarate, an anorectic drug, and the development of obstructive pulmonary hypertension.

Main Methods:

• Retrospective study of 40 patients diagnosed with obstructive pulmonary hypertension in Basle, Switzerland (1966-1968).
• Analysis of patient drug history, focusing on the use of anorectic medications.

Main Results:

• 32 out of 40 patients (80%) with obstructive pulmonary hypertension reported taking aminorex fumarate.
• Characteristic symptoms included rapidly progressing exertional dyspnea, chest pain, and syncope on effort.
• No other common causes of pulmonary vascular disease were identified in the affected patients.

Conclusions:

• The high prevalence of aminorex fumarate use among patients with obstructive pulmonary hypertension suggests a potential drug-induced etiology.
• Further research is warranted to confirm the role of aminorex fumarate in causing pulmonary hypertension.